Tudor Investment Corp
PRME icon

Tudor Investment Corp’s Prime Medicine PRME Stock Holding History

Tudor Investment Corp’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
+61,546
New +$234K ﹤0.01% 3338
2025
Q4 		– Sell
-62,981
Closed -$349K – 3945
2025
Q3 		$349K Buy
+62,981
New +$256K ﹤0.01% 2886
2025
Q2 		– Sell
-60,368
Closed -$120K – 3659
2025
Q1 		$120K Buy
+60,368
New +$154K ﹤0.01% 2926
2024
Q2 		– Sell
-61,295
Closed -$429K – 2699
2024
Q1 		$429K Buy
+61,295
New +$465K ﹤0.01% 1713

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Tudor Investment Corp's PRME Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Prime Medicine (PRME) in Q1 2026: 61,546 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #3338 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in PRME as recently as Q3 2025.

Tudor Investment Corp first reported a position in PRME in Q1 2024 and has held it in 4 quarters since. The position peaked at $429K in Q1 2024. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Tudor Investment Corp held 61,546 shares of Prime Medicine worth $214K as of Q1 2026.
  • Prime Medicine was a new Tudor Investment Corp position in Q1 2026.
  • Prime Medicine made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #3338 holding.
  • Tudor Investment Corp first reported a position in Prime Medicine in Q1 2024 and has held it in 4 quarters since.
  • Tudor Investment Corp's Prime Medicine position peaked at $429K in Q1 2024.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.